Literature DB >> 28073941

Prognostic roles of tetrahydroxy bile acids in infantile intrahepatic cholestasis.

Chee-Seng Lee1,2, Akihiko Kimura3, Jia-Feng Wu1, Yen-Hsuan Ni1,4, Hong-Yuan Hsu1,5, Mei-Hwei Chang1,4, Hiroshi Nittono6, Huey-Ling Chen7,4,5.   

Abstract

Tetrahydroxy bile acids (THBAs) are hydrophilic and are present at minimal or undetectable levels in healthy human adults, but are present at high levels in bile salt export pump (abcb11)-knockout mice. The roles of THBAs in human cholestatic diseases are unclear. We aimed to investigate the presence of THBAs in patients with infantile intrahepatic cholestasis and its correlation with outcome. Urinary bile acids (BAs) were analyzed by GC-MS. Data were compared between good (n = 21) (disease-free before 1 year old) and poor prognosis groups (n = 19). Good prognosis patients had a higher urinary THBA proportion than poor prognosis patients [25.89% (3.45-76.73%) vs. 1.93% (0.05-48.90%)]. A urinary THBA proportion >7.23% predicted good prognosis with high sensitivity (95.24%), specificity (84.21%), and area under the curve (0.91) (P < 0.0001). A THBA proportion 7.23% was an independent factor for decreased transplant-free survival (hazard ratio = 7.16, confidence interval: 1.24-41.31, P = 0.028). Patients with a confirmed ABCB11 or tight junction protein 2 gene mutation (n = 7) had a minimally detectable THBA proportion (0.23-2.99% of total BAs). Three patients with an ATP8B1 mutation had an elevated THBA proportion (7.51-37.26%). In conclusion, in addition to disease entity as a major determinant of outcome, a high THBA level was associated with good outcome in the infantile intrahepatic cholestasis patients.
Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  bile acid metabolism; bile salts; clinical studies; cytochrome P450; diseases; liver; progressive familial intrahepatic cholestasis

Mesh:

Substances:

Year:  2017        PMID: 28073941      PMCID: PMC5335591          DOI: 10.1194/jlr.P070425

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  37 in total

1.  Differences in presentation and progression between severe FIC1 and BSEP deficiencies.

Authors:  Ludmila Pawlikowska; Sandra Strautnieks; Irena Jankowska; Piotr Czubkowski; Karan Emerick; Anthony Antoniou; Catherine Wanty; Bjorn Fischler; Emmanuel Jacquemin; Sami Wali; Samra Blanchard; Inge-Merete Nielsen; Billy Bourke; Shirley McQuaid; Florence Lacaille; Jane A Byrne; Albertien M van Eerde; Kaija-Leena Kolho; Leo Klomp; Roderick Houwen; Peter Bacchetti; Steven Lobritto; Vera Hupertz; Patricia McClean; Giorgina Mieli-Vergani; Benjamin Shneider; Antal Nemeth; Etienne Sokal; Nelson B Freimer; A S Knisely; Philip Rosenthal; Peter F Whitington; Joanna Pawlowska; Richard J Thompson; Laura N Bull
Journal:  J Hepatol       Date:  2010-04-13       Impact factor: 25.083

Review 2.  Defects in bile acid biosynthesis--diagnosis and treatment.

Authors:  Kenneth D R Setchell; James E Heubi
Journal:  J Pediatr Gastroenterol Nutr       Date:  2006-07       Impact factor: 2.839

3.  Profile of urinary bile acids in infants and children: developmental pattern of excretion of unsaturated ketonic bile acids and 7beta-hydroxylated bile acids.

Authors:  A Kimura; R Mahara; T Inoue; Y Nomura; T Murai; T Kurosawa; M Tohma; K Noguchi; A Hoshiyama; T Fujisawa; H Kato
Journal:  Pediatr Res       Date:  1999-04       Impact factor: 3.756

Review 4.  Immaturity of the enterohepatic circulation in early life: factors predisposing to "physiologic" maldigestion and cholestasis.

Authors:  W F Balistreri; J E Heubi; F J Suchy
Journal:  J Pediatr Gastroenterol Nutr       Date:  1983-05       Impact factor: 2.839

5.  Hepatic bile acid metabolism and expression of cytochrome P450 and related enzymes are altered in Bsep (-/-) mice.

Authors:  Eugene Hrycay; Dana Forrest; Lin Liu; Renxue Wang; Jenny Tai; Anand Deo; Victor Ling; Stelvio Bandiera
Journal:  Mol Cell Biochem       Date:  2014-01-08       Impact factor: 3.396

6.  Novel pathways of bile acid metabolism involving CYP3A4.

Authors:  Karl Bodin; Ulla Lindbom; Ulf Diczfalusy
Journal:  Biochim Biophys Acta       Date:  2005-02-21

7.  Large amounts of 1 beta-hydroxylated bile acids in urine during taurine therapy.

Authors:  A Kimura; K Ushijima; R Yamakawa; T Inokuchi; M Kage; R Mahara; M Tohma
Journal:  Kurume Med J       Date:  1992

8.  Profile of urinary bile acids in familial intrahepatic cholestasis with Coombs' negative haemolytic anaemia.

Authors:  A Kimura; K Ushijima; M Suzuki; M Tohma; T Inokuchi; H Kato
Journal:  Acta Paediatr       Date:  1995-10       Impact factor: 2.299

9.  Appearance of atypical 3 alpha,6 beta,7 beta,12 alpha-tetrahydroxy-5 beta-cholan-24-oic acid in spgp knockout mice.

Authors:  Shahid Perwaiz; Dana Forrest; Diane Mignault; Beatriz Tuchweber; M James Phillip; Renxue Wang; Victor Ling; Ibrahim M Yousef
Journal:  J Lipid Res       Date:  2002-12-01       Impact factor: 5.922

10.  Bile acid metabolism in early life: studies of amniotic fluid.

Authors:  M Nakagawa; K D Setchell
Journal:  J Lipid Res       Date:  1990-06       Impact factor: 5.922

View more
  7 in total

1.  Quantification of common and planar bile acids in tissues and cultured cells.

Authors:  Stephanie J Shiffka; Jace W Jones; Linhao Li; Ann M Farese; Thomas J MacVittie; Hongbing Wang; Peter W Swaan; Maureen A Kane
Journal:  J Lipid Res       Date:  2020-07-22       Impact factor: 5.922

2.  Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2-/- mice.

Authors:  Renxue Wang; Jonathan A Sheps; Lin Liu; Jun Han; Patrick S K Chen; Jason Lamontagne; Peter D Wilson; Ian Welch; Christoph H Borchers; Victor Ling
Journal:  J Lipid Res       Date:  2018-11-11       Impact factor: 5.922

Review 3.  Animal models to study bile acid metabolism.

Authors:  Jianing Li; Paul A Dawson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-05-18       Impact factor: 5.187

4.  Changes in plasma bile acid profiles after partial internal biliary diversion in PFIC2 patients.

Authors:  Teng Liu; Ren-Xue Wang; Jun Han; Yi-Ling Qiu; Christoph H Borchers; Victor Ling; Jian-She Wang
Journal:  Ann Transl Med       Date:  2020-03

Review 5.  Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome.

Authors:  Piero Portincasa; Agostino Di Ciaula; Gabriella Garruti; Mirco Vacca; Maria De Angelis; David Q-H Wang
Journal:  Nutrients       Date:  2020-11-30       Impact factor: 5.717

6.  A Japanese prospective multicenter study of urinary oxysterols in biliary atresia.

Authors:  Ken-Ichiro Konishi; Tatsuki Mizuochi; Hajime Takei; Ryosuke Yasuda; Hirotaka Sakaguchi; Jun Ishihara; Yugo Takaki; Masahiro Kinoshita; Naoki Hashizume; Suguru Fukahori; Hiromichi Shoji; Go Miyano; Koichiro Yoshimaru; Toshiharu Matsuura; Yukihiro Sanada; Takahisa Tainaka; Hiroo Uchida; Yumiko Kubo; Hiromu Tanaka; Hideyuki Sasaki; Tsuyoshi Murai; Jun Fujishiro; Yushiro Yamashita; Masaki Nio; Hiroshi Nittono; Akihiko Kimura
Journal:  Sci Rep       Date:  2021-03-02       Impact factor: 4.379

7.  Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2-/- mouse model of sclerosing cholangitis via immunomodulatory effects.

Authors:  Claudia D Fuchs; Emmanuel D Dixon; Tim Hendrikx; Veronika Mlitz; Annika Wahlström; Marcus Ståhlman; Hubert Scharnagl; Tatjana Stojakovic; Christoph J Binder; Hanns-Ulrich Marschall; Michael Trauner
Journal:  Hepatol Commun       Date:  2022-06-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.